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Case report
An 88-year-old female presented to the Emergency De-
partment complaining of  acute-on-chronic back pain and 
progressive, bilateral, lower-extremity numbness and weak-
ness for approximately three weeks. The patient endorsed a 
history of  hypertension, osteoporosis, and long-standing 
compression fractures involving multiple thoracolumbar 
vertebrae. The patient had been in her usual state of  
health, ambulating with a walker and living independently, 
but over the 2 to 3 weeks before presentation began experi-
encing episodes of  radicular pain radiating down both legs, 
with multiple falls from standing. When her weakness in-
creased to the point where she was no longer able to walk, 
she was compelled to seek medical attention.
On physical examination, she was alert and oriented. She 
had full motor strength in her upper extremities. However, 
she could flex her lower extremities only against gravity, not 
against added resistance. 
Sensation was intact at 
all points tested.
   She was fitted with a 
thoracolumbar sacral 
orthosis (TLSO) brace, 
and intravenous corticos-
teroids were administered. 
CT of  the thoracolumbar spine revealed a large (7.0 x 5.5 
x 3.0 cm) enhancing lesion involving the T8, T9, and T10 
vertebral bodies (Fig. 1). The T9 vertebral body was largely 
destroyed, with only the spinous process remaining. The T8 
vertebral body showed greater than 70% height loss, and 
T10 approximately 10% height loss. Fracture kyphosis of  
47 degrees was measured at T9-10. Subsequent 
gadolinium-enhanced MR imaging demonstrated extensive 
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Figure 1. 88-year-old fe-
male with follicular thyroid 
carcinoma. Contrast-
enhanced sagittal CT 
shows a rounded soft-
tissue lesion (arrow) of 
the midthoracic spine with 
destruction of the T9 ver-
tebral body and associ-
ated focal kyphosis. The 
T8 and T10 vertebrae 
demonstrate severe 
height loss and sclerosis.
vertebral marrow infiltration by enhancing tumor (Fig. 2). 
There was severe effacement of  the central canal and of  
both neuroforamina at T9-10, with marked displacement 
but no significant cord flattening or signal abnormality (Fig. 
2).
Accompanying contrast-enhanced CT of  the chest, ab-
domen, and pelvis revealed a 1.1-cm pulmonary nodule in 
the right lower lobe, with smaller nodules scattered 
throughout both lungs. Also present was 
a complex, multiseptated nodule arising 
from the inferior aspect of  the left thy-
roid lobe measuring 2.8 x 2.8 x 3.0 cm 
(Fig. 3).
   The patient was evaluated emergently 
by the orthopedic and neurosurgical 
services. Due to her advanced age and 
comorbidities, she was felt to be a poor 
candidate for neurosurgical 
decompression/stabilization. To guide 
nonoperative management, a CT-guided 
biopsy of  the vertebral lesion was per-
formed under conscious sedation. 
The needle-core biopsy consisted of  
micro- and normofollicular tissue with 
follicles containing homogeneous mate-
rial, histologically indistinguishable from 
that of  an adenoma or a non-neoplastic 
thyroid (Fig. 4). The tissue’s expression 
of  Thyroid Transcription Factor 1 and 
Thyroglobulin (Figs. 5 and 6, respec-
tively) confirmed its thyroid immuno-
phenotype, sealing the diagnosis of  
metastatic thyroid follicular carcinoma. 
A serum thyrogobulin level measured 
8388.5 ng/mL. 
   The radiation oncology service was 
consulted, and the patient underwent 
hypofractionated external-beam radio-
therapy for palliative intent. The T7-
T11 spine levels were treated using a single 18MV postero-
anterior field. CT-based planning and multileaf  collimators 
were used to shape the beam. She received a dose of  2000 
cGy, delivered in 5 fractions over 5 days. She was treated 
prone due to discomfort when lying on her back. She also 
was maintained on oral dexamethasone, which was tapered 
prior to discharge. She tolerated this therapeutic process 
without significant adverse sequelae.
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Figure 2. 88-year-old female with follicular thyroid carcinoma. Sagittal T1WI se-
quence with fat suppression and gadolinium contrast (A) demonstrates enhance-
ment of the destructive lesion involving the T8 through T10 vertebrae. Sagittal 
STIR sequence (B) shows severe effacement of the central canal with posterior 
displacement of the spinal cord. No definite cord signal abnormality is identified.
Figure 3. 88-year-old female with follicular thyroid carcinoma. Coronal (A) and axial (B) contrast-enhanced CT demonstrates a 
complex, multiseptated nodule (arrows) arising from the inferior aspect of the left lobe of the thyroid gland.
The patient was referred to a multidisciplinary tumor 
board to evaluate options for further management. Thyroi-
dectomy was considered, for debulking of  her tumor and to 
facilitate radioiodine therapy, but because of  her tenuous 
performance status and medical comorbidities, her surgical 
candidacy was deferred. One option discussed was recom-
binant, TSH-driven, radioiodine ablation of  the thyroid 
followed by a second, higher-dose radioiodine regimen to 
target her metastatic disease. These procedures could not 
be performed in the near term, given the patient's exposure 
to iodinated contrast during her initial diagnostic workup. 
And ultimately, it was decided that although her well-
differentiated thyroid cancer likely would respond to sys-
temic radioiodine therapy, there probably would not be 
significant debulking or stabilization of  the T8-T10 lesion. 
Instead, it was recommended that the patient undergo 
thyroxin supplementation and TSH suppression, as toler-
ated, with intent to reduce the impetus for further tumor 
growth. The patient agreed to this course of  action and, at 
the time of  this report, is continuing her outpatient therapy. 
Although there have been no clinical signs of  worsening, 
she has not regained significant function in her lower 
extremities.
Discussion
Follicular thyroid carcinoma (FTC) accounts for 15-30% 
of  all malignant thyroid neoplasms (3). In the majority of  
cases, FTC presents as a solitary thyroid nodule (4); such 
localized cases are associated with favorable outcomes, with 
an 85% overall 10-year relative survival (2). Although FTC 
is less common than papillary carcinoma (2), it tends to be 
more aggressive, with distant metastasis present in roughly 
10 to 25% of  newly diagnosed cases (5-8), and with higher 
likelihood of  subsequent development of  metastatic disease 
(9, 10).
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Figure 4. 88-year-old female with follicular thyroid carci-
noma. Follicular carcinoma metastatic to the vertebral body, 
medium-power view, H&E stained section. The biopsy con-
sists of well-defined follicular tissue with variable-sized folli-
cles containing homogeneous acellular material (colloid). 
The degree of differentiation results in a micro- and normo-
follicular appearance indistinguishable from that of a thyroid 
adenoma or a non-neoplastic thyroid condition.
Figure 5. 88-year-old female with follicular thyroid carci-
noma. Follicular carcinoma metastatic to the vertebral body, 
high-power view, thyroid transcription factor (TTF-1) immu-
nostain. The carcinoma follicular epithelium demonstrates 
strong nuclear TTF-1 positivity consistent with thyroid im-
munophenotype. However, in this patient with pulmonary 
nodules, broncho-pulmonary tumor of primary origin enters 
the histologic differential diagnosis. The thyroglobulin ex-
pression (Fig. 6) resolved this issue.
Figure 6. 88-year-old female with follicular thyroid carci-
noma. Follicular carcinoma metastatic to the vertebral body, 
high-power view, thyroglobulin immunostain. The carci-
noma demonstrates diagnostic primary thyroid immuno-
phenotype with strong thyroglobulin expression, especially 
within colloid pools.
While local nodal involvement by differentiated thyroid 
cancer is not considered to be of  prognostic significance (5), 
distant metastases are associated with generally poor out-
comes (9, 11, 12) and represent the primary cause of  death 
in these patients (13). While papillary thyroid cancer 
spreads through lymphatics, follicular thyroid tumors have 
a tendency to spread hematogenously to locations such as 
the bones, lungs, brain, liver, and adrenals, with skeletal 
involvement being most common (8, 14).
Skeletal metastases from follicular thyroid cancer fre-
quently involve the vertebrae, pelvis, sternum, long bones, 
and ribs (15). In a review of  780 patients with differentiated 
thyroid cancer, Marcocci found that of  the 18 patients pre-
senting with skeletal metastases, all had either pain or 
pathologic fracture (16). The vertebrae were involved in 
27% of  these cases (16). These bone metastases can feature 
follicular structures so well differentiated as to closely simu-
late those of  non-neoplastic thyroid. This is the source for 
the picturesque but incorrect and deservedly obsolete ex-
pression “benign metastasizing goiter" (17). The high de-
gree of  differentiation is also demonstrated by the ability of 
the follicular structures to incorporate radioactive iodine, a 
feature that is exploited for diagnostic and therapeutic 
purposes.
As with any malignancy, vertebral involvement of  thyroid 
metastases commonly requires surgical attention. Such pa-
tients may present with intractable pain and spinal instabil-
ity with or without central canal compromise; any of  these 
conditions may warrant surgical intervention, particularly 
when the spinal lesions have proven resistant to nonsurgical 
therapies such as radioiodine or external radiotherapy (18, 
19). External-beam radiotherapy often is considered a pal-
liative intervention due to the relative radioresistance of  
thyroid carcinoma (18, 20). Bisphosphonate therapy may be 
effective in preventing fractures, spinal cord compression, 
and hypercalcemia secondary to skeletal thyroid metastases 
(21).
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